GENERAL COMMENTS
In my opinion the study design can be implemented in some points -Comorbidities of patients should be considered (above all migraine and vascular disorders). Why to exclude overanxious people? -The duration of BPPV before repositioning maneuvers and the total number of maneuvers should be saved and considered in statistical analisis -Exclusion of previous vestibular disorders should be assessed through a bedside and possibly a video-HIT (specify the battery of performed tests) -Drug therapy could be performed for all the month rather than only 7 days? About outcomes: -the number of days with RD should be saved -A DHI test is suggested to measure dizziness of subjects after repositioning maneuvers Specific considerations page 6 line 6 vertigo instead of dizziness Page 6 Has superior canal been considered? Page 11 last line: why patients after 3 CRPs were excluded? Page 12: another weak point is that only few patients will perform MRI; the significance of MRI is to exclude cerebellar disorders rather than of the ponto cerebellar angle 
The topic of this manuscript (to compare the effectiveness of vestibular rehabilitation vs betahistine vs vestibular rehabilitation plus betahistine) to improve residual dizziness after successful maneuvers in patients with benign positional paroxysmal vertigo is of interest. The paper is correctly written and presented; abstract and introduction are appropriate, and methodology is adequately described. References are appropriate too. However, before its acceptance, I recommend the authors clarify and / or discuss several points.
Patients are included if they present residual dizziness two days after a successful maneuver. Two days is a very short time; residual dizziness can disappear spontaneously along the first week after the maneuver. It is possible that improvement attributed to the treatment may be actually spontaneous recovery. The groups of vestibular rehabilitation perform exercises five days per week (only one day at the clinic, home exercises the other four days). Why not seven days per week? Home exercises can be performed weekends too. The betahistine group are prescribed with betahistine for seven days. Why only one week, while vestibular rehabilitation is performed for four weeks? One of the secondary outcomes is the "Quality of life measured by DHI". DHI is a very good tool to quantify the perceived handicap due to instability, but is not a questionnaire of quality of life.
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1
In my opinion the study design can be implemented in some points -Comorbidities of patients should be considered (above all migraine and vascular disorders). Why to exclude overanxious people?
Author's answer: Thank you for your comments. We will collect the demographic and clinical characteristics upon baseline checkup. These variables will be compared in statistical analysis to see if they are evenly distributed across three groups. We clarified this point in revised version as follows:
Demographic and clinical data collected will include: age, gender, education, employment, marital status, coexistent systemic diseases and medication intake, date of onset, duration of symptom from onset to treatment, involved ear side and canal, the number of CRP, DHI score after CRP.
For the second question, since we have observed that presence of anxiety or depression may be a barrier for achieving efficacy when performing VR. However, in light of your question, we were aware that excluding overanxious people would be inappropriate. So, we deleted this condition as an exclusion criterion in the revised version.
-The duration of BPPV before repositioning maneuvers and the total number of maneuvers should be saved and considered in statistical analysis.
Author's answer: Thanks for the reminder. We have added information about clinical feature data collection at baseline, as illustrated above.
-
Exclusion of previous vestibular disorders should be assessed through a bedside and possibly a video-HIT (specify the battery of performed tests) Author's answer: Routinely, we only perform V-Hit for those showing/presenting spontaneously nystagmus or whose vertigo is not head-motion-induced. In this study, V-Hit is not considered as a routine exam. We exclude previous vestibular disorders through comprehensive history taking and bedside examination, e.g., VNG and caloric test. The performed tests battery has been clarified in the revised draft as follows: After obtaining written consent form, the principal investigator will fully review the participant's medical history, execute physical examination and perform videonystagmography (VNG) including caloric test, to rule out any central nervous system pathologies or other vestibular diseases. Diagnostic test for BPPV will be repeated to make sure findings are negative. Pure-tone audiometry and tympanometry will be checked. Gait and balance will also be assessed (Romberg, sharpened Romberg). Whenever necessary, imaging exam such as CT scan or MRI is supplemented to exclude cerebellar disorders. The purpose of above-mentioned examinations is to confirm the diagnosis and validate the homogeneity of all participants who take part in current study.
Drug therapy could be performed for all the month rather than only 7 days? Author's answer: We noted this weak point and did revise the drug therapy by prescribing betahistine for 4 weeks. We made this revision in abstract and methodology section as well.
About outcomes:
the number of days with RD should be saved
